X-linked inheritance of Fanconi anemia complementation group B

被引:231
|
作者
Meetei, AR
Levitus, M
Xue, YT
Medhurst, AL
Zwaan, M
Ling, C
Rooimans, MA
Bier, P
Hoatlin, M
Pals, G
de Winter, JP
Wang, WD
Joenje, H
机构
[1] NIA, Genet Lab, NIH, Baltimore, MD 21224 USA
[2] Vrije Univ Amsterdam, Med Ctr, Dept Clin Genet, NL-1081 BT Amsterdam, Netherlands
[3] Vrije Univ Amsterdam, Med Ctr, Dept Pediat & Hematol Oncol, NL-1007 MB Amsterdam, Netherlands
[4] Oregon Hlth & Sci Univ, Div Mol Med & Mol Med Genet, Portland, OR 97239 USA
基金
美国国家卫生研究院;
关键词
D O I
10.1038/ng1458
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Fanconi anemia is an autosomal recessive syndrome characterized by diverse clinical symptoms, hypersensitivity to DNA crosslinking agents, chromosomal instability and susceptibility to cancer(1,2). Fanconi anemia has at least 11 complementation groups (A, B, C, D1, D2, E, F, G, I, J, L)(3,4); the genes mutated in 8 of these have been identified. The gene BRCA2 was suggested to underlie complementation group B, but the evidence is inconclusive(5). Here we show that the protein defective in individuals with Fanconi anemia belonging to complementation group B is an essential component of the nuclear protein 'core complex' responsible for monoubiquitination of FANCD2, a key event in the DNA-damage response pathway associated with Fanconi anemia and BRCA(3,6,7). Unexpectedly, the gene encoding this protein, FANCB, is localized at Xp22.31 and subject to X-chromosome inactivation. X-linked inheritance has important consequences for genetic counseling of families with Fanconi anemia belonging to complementation group B. Its presence as a single active copy and essentiality for a functional Fanconi anemia-BRCA pathway make FANCB a potentially vulnerable component of the cellular machinery that maintains genomic integrity.
引用
收藏
页码:1219 / 1224
页数:6
相关论文
共 50 条
  • [31] Germ line Fanconi anemia complementation group C mutations and pancreatic cancer
    Couch, FJ
    Johnson, MR
    Rabe, K
    Boardman, L
    McWilliams, R
    de Andrade, M
    Petersen, G
    CANCER RESEARCH, 2005, 65 (02) : 383 - 386
  • [32] A rapid method for retroviral mediated subtyping of complementation group in Fanconi anemia patients
    Chandra, S
    Levran, O
    Jurickova, I
    Mass, C
    Kapur, R
    Hanenberg, H
    Auerbach, AD
    Williams, DA
    BLOOD, 2004, 104 (11) : 400B - 401B
  • [33] Fanconi anemia, complementation group A (FancA) overexpression confers radioresistance to oral keratinocytes
    Gimenez-Aznar, I.
    Michna, A.
    Ludwig, H.
    Braselmann, H.
    Klein, D.
    Ohrt, M.
    Schoetz, U.
    Kuger, S.
    Schneider, L.
    Schuettrumpf, L.
    Jendrossek, V.
    Belka, C.
    Zangen, V.
    Unger, K.
    Zitzelsberger, H.
    Lauber, K.
    Hess, J.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S121 - S121
  • [34] The Fanconi anemia complementation group C gene product: structural evidence of multifunctionality
    Pang, QS
    Christianson, TA
    Keeble, W
    Diaz, J
    Faulkner, GR
    Reifsteck, C
    Olson, S
    Bagby, GC
    BLOOD, 2001, 98 (05) : 1392 - 1401
  • [35] Lentivirus mediated gene therapy for Fanconi anemia complementation group a: the Seattle experience
    Adair, J. E.
    Becker, P.
    Chandrasekaran, D.
    Burroughs, L.
    Woolfrey, A.
    Choi, G.
    Kiem, H. P.
    HUMAN GENE THERAPY, 2016, 27 (11) : A112 - A113
  • [36] Fanconi anemia complementation group E: Clinical and cytogenetic data of the first patient
    Wegner, RD
    Henrichs, I
    Joenje, H
    SchroederKurth, T
    CLINICAL GENETICS, 1996, 50 (06) : 479 - 482
  • [37] A trial of gene therapy in a patient with complementation group C Fanconi anemia (FAC)
    Liu, JM
    Young, NS
    Carter, CS
    Read, EJ
    Pensiero, M
    Glader, B
    Grompe, M
    Walsh, CE
    BLOOD, 1995, 86 (10) : 1169 - 1169
  • [38] Fanconi anemia complementation group A cells are hypersensitive to chromium (VI)-induced toxicity
    Vilcheck, SK
    O'Brien, TJ
    Pritchard, DE
    Ha, LN
    Ceryak, S
    Fornsaglio, JL
    Patierno, SR
    ENVIRONMENTAL HEALTH PERSPECTIVES, 2002, 110 : 773 - 777
  • [39] IDENTIFICATION OF 2 COMPLEMENTATION GROUPS IN FANCONI ANEMIA
    DUCKWORTHRYSIECKI, G
    CORNISH, K
    CLARKE, CA
    BUCHWALD, M
    SOMATIC CELL AND MOLECULAR GENETICS, 1985, 11 (01) : 35 - 41
  • [40] Animal models for X-linked sideroblastic anemia
    Yamamoto, M
    Nakajima, O
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2000, 72 (02) : 157 - 164